A new survey from the National Council for Mental Wellbeing shows that four in five behavioral health workers were concerned that labor shortages in their field “negatively impact society as a whole.”

“As we prepare to observe Mental Health Awareness Month, we urge policymakers to listen to the voices of those in the field,” National Council for Mental Wellbeing President and CEO Chuck Ingoglia said in a statement.

“Behavioral health organizations are seeing an increase in the severity of cases, and a backlog of young people in need of care has led to more youth being seen in emergency departments," he added. "Taking steps now to bolster the workforce through increased recruitment and retention efforts and the continued expansion of Certified Community Behavioral Health Clinics will give organizations that provide mental health treatment and substance use care the resources they need to meet capacity.”

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More